ArticleScience advances2026

EZH2 inhibition via GSK-126 mitigates EndMT and atherosclerosis in diabetes: A translational epigenetic approach.

Misbah Aziz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.